Recent news

Archived news



More technical details, concerning the patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology, have been published in the Data in Brief international journal (Data in Brief (2020) 28:105069).

Data in brief
.pdf
Download PDF • 3.14MB





The patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology, designed for the development of new generation vaccines, biologics, biosimilars, industrial and environmental was published in one of the top journals in the field – Materials Science & Engineering C (IF= 5). This publication shows in more detail the biotechnology described in the patents using legal language as well as adds more developments and is written in scientific language for readers convenience.


Materials Science & Engineering C
.pdf
Download PDF • 6.41MB



Our break-through recombinant DNA biotechnology for the construction of new generation vaccines, biologics, biosymilars, industrial and environmental processes was granted the Republic of Poland patent no. 228341.


Patent EP 3 134 426 B1
.pdf
Download PDF • 1.91MB